What is a stock summary page? Click here for an overview.
Current and historical daily PE Ratio for MKKGY (
Merck KGaA
) from 2007 to Apr 29 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Merck KGaA stock (MKKGY) PE ratio as of Apr 29 2025 is 20.57.
More Details
Merck KGaA (MKKGY) PE Ratio (TTM) Chart
Merck KGaA (MKKGY) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Merck KGaA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2025-04-29 | 20.6 | 2025-02-24 | 20.6 |
| 2025-04-28 | 20.6 | 2025-02-21 | 20.4 |
| 2025-04-25 | 19.8 | 2025-02-20 | 20.7 |
| 2025-04-24 | 20.1 | 2025-02-19 | 20.4 |
| 2025-04-23 | 19.8 | 2025-02-18 | 20.6 |
| 2025-04-22 | 19.6 | 2025-02-14 | 20.5 |
| 2025-04-21 | 18.9 | 2025-02-13 | 20.6 |
| 2025-04-17 | 19.2 | 2025-02-12 | 20.3 |
| 2025-04-16 | 19.3 | 2025-02-11 | 20.2 |
| 2025-04-15 | 19.0 | 2025-02-10 | 20.1 |
| 2025-04-14 | 19.4 | 2025-02-07 | 20.9 |
| 2025-04-11 | 19.2 | 2025-02-06 | 21.3 |
| 2025-04-10 | 18.4 | 2025-02-05 | 21.3 |
| 2025-04-09 | 18.8 | 2025-02-04 | 21.2 |
| 2025-04-08 | 17.6 | 2025-02-03 | 21.5 |
| 2025-04-07 | 18.0 | 2025-01-31 | 21.9 |
| 2025-04-04 | 18.3 | 2025-01-30 | 22.9 |
| 2025-04-03 | 19.3 | 2025-01-29 | 22.4 |
| 2025-04-02 | 19.8 | 2025-01-28 | 22.6 |
| 2025-04-01 | 19.7 | 2025-01-27 | 22.2 |
| 2025-03-31 | 19.8 | 2025-01-24 | 22.0 |
| 2025-03-28 | 20.4 | 2025-01-23 | 21.9 |
| 2025-03-27 | 20.0 | 2025-01-22 | 21.8 |
| 2025-03-26 | 19.7 | 2025-01-21 | 21.8 |
| 2025-03-25 | 20.4 | 2025-01-17 | 21.0 |
| 2025-03-24 | 20.5 | 2025-01-16 | 21.3 |
| 2025-03-21 | 20.6 | 2025-01-15 | 21.1 |
| 2025-03-20 | 20.7 | 2025-01-14 | 21.0 |
| 2025-03-19 | 21.1 | 2025-01-13 | 20.8 |
| 2025-03-18 | 21.4 | 2025-01-10 | 21.1 |
| 2025-03-17 | 21.6 | 2025-01-08 | 21.3 |
| 2025-03-14 | 21.2 | 2025-01-07 | 21.7 |
| 2025-03-13 | 21.0 | 2025-01-06 | 21.4 |
| 2025-03-12 | 21.1 | 2025-01-03 | 20.8 |
| 2025-03-11 | 21.2 | 2025-01-02 | 20.7 |
| 2025-03-10 | 21.0 | 2024-12-31 | 20.7 |
| 2025-03-07 | 21.3 | 2024-12-30 | 20.6 |
| 2025-03-06 | 21.8 | 2024-12-27 | 21.5 |
| 2025-03-05 | 21.4 | 2024-12-26 | 21.5 |
| 2025-03-04 | 20.9 | 2024-12-24 | 21.3 |
| 2025-03-03 | 20.9 | 2024-12-23 | 21.2 |
| 2025-02-28 | 20.4 | 2024-12-20 | 21.2 |
| 2025-02-27 | 20.2 | 2024-12-19 | 21.1 |
| 2025-02-26 | 20.6 | 2024-12-18 | 21.3 |
| 2025-02-25 | 20.8 | 2024-12-17 | 21.6 |
Merck KGaA (MKKGY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Merck KGaA
NAICS : 325412
SIC : 2834
ISIN : US5893392093
Share Class Description:
MKKGY: ADRCompare
Compare
Traded in other countries / regions
MRK.Germany0O14.UKMKKGY.USA1MRK.ItalyMRCK.AustriaMRK.BulgariaMER.SwitzerlandMRK1.Mexico IPO Date
2007-09-07Description
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers